Trial | Studied treatment | Control treatment | patients | ROB | Result | NCT |
---|
|
A to Z, 2004 | simvastatin | placebo | acute coronary syndrome | | Negative | |
|
SEAS, 2008 | ezetimibe+simvastatin | placebo | aortic stenosis | Low risk of bias | Negative | NCT00092677 |
|
Christenson, 1999 | preoperative simvastatin | no treatment | | | Negative | |
|
MAAS, 1994 | simvastatin | placebo | secondary prevention | Exploratory | Negative | |
4S, 1994 | simvastatin | placebo | secondary prevention | Low risk of bias | Conclusive | |
CIS, 1997 | simvastatin | placebo | secondary prevention | Exploratory | Negative | |
4S (elderly subgroup), 1997 | simvastatin | placebo | elderly | Exploratory | Suggesting | |
4S (diabetic sub group), 1999 | simvastatin | placebo | diabetic patients | Exploratory | Suggesting | |
HPS (diabetic sub group), 2002 | simvastatin | placebo | diabetic patients | Exploratory | Suggesting | |
HPS, 2002 | simvastatin | placebo | secondary prevention | Low risk of bias | Conclusive | |
HPS (elderly subgroup), 2002 | simvastatin | placebo | elderly | Exploratory | Suggesting | |
HPS (women subgroup) , 2002 | Simvastatin | placebo | women | Exploratory | Suggesting | |
Mondillo, 2003 | simvastatin | placebo | Peripheral Arterial Disease | Exploratory | - | |
Aronow , 2003 | simvastatin | placebo | Peripheral Arterial Disease | Exploratory | - | |
Node, 2003 | simvastatin | placebo | heart failure | | Negative | |
HPS (diabetic primary prevention sub group), 2003 | simvastatin | placebo | diabetic | Exploratory | - | |
A to Z, 2004 | simvastatin | placebo | acute coronary syndrome | | Negative | |
HPS (post troke sub group), 2004 | simvastatin | placebo | post stroke | Exploratory | Suggesting | |
Hong, 2005 | simvastatin | control | heart failure | Risk of bias | Negative | |
Landmesser, 2005 | simvastatin | ezetimibe | heart failure | | - | |
SEAS, 2008 | ezetimibe+simvastatin | placebo | aortic stenosis | Low risk of bias | Negative | NCT00092677 |
SEARCH, 2010 | simvastatin high dose | simvastatin | secondary prevention | Low risk of bias | Suggesting | NCT00124072 |
|
4S (diabetic sub group), 1999 | simvastatin | placebo | diabetic patients | Exploratory | Suggesting | |
HPS (diabetic sub group), 2002 | simvastatin | placebo | diabetic patients | Exploratory | Suggesting | |
|
Node, 2003 | simvastatin | placebo | heart failure | | Negative | |
Hong, 2005 | simvastatin | control | heart failure | Risk of bias | Negative | |
Landmesser, 2005 | simvastatin | ezetimibe | heart failure | | - | |
|
HPS (sub group), 2002 | simvastatin | placebo | Peripheral Arterial Disease | Low risk of bias | - | |
Mondillo, 2003 | simvastatin | placebo | Peripheral Arterial Disease | Exploratory | - | |
Aronow , 2003 | simvastatin | placebo | Peripheral Arterial Disease | Exploratory | - | |
|
4S, 1994 | simvastatin | placebo | secondary prevention | Low risk of bias | Conclusive | |
|
HPS (post troke sub group), 2004 | simvastatin | placebo | post stroke | Exploratory | Suggesting | |